Edward Agyare
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
- Oncology 12
- Pancreatic and Hepatic Oncology Research 9
- Colorectal Cancer Treatments and Studies 2
- Lung Cancer Research Studies 2
- Biomaterials 12
- Nanoparticle-Based Drug Delivery 12
- Co-authors
- José G. Treviño (7 shared papers)Sunil Krishnan (4 shared papers)Bo Han (10 shared papers)Sunil Krishnan (1 shared paper)Felix Amissah (1 shared paper)Edward Ofori (2 shared papers)Patrick W. Underwood (2 shared papers)Jens T. Rosenberg (2 shared papers)
- Journals
- BMC Cancer (2 papers)Cancers (2 papers)Scientific Reports (1 paper)AAPS PharmSciTech (1 paper)Journal of the National Medical Association (1 paper)
- Partner nations
- United StatesCameroon
In The Last Decade
Edward Agyare
20 papers receiving 373 citations
Peers
Comparison fields: 5 of 79
- Biomaterials 201
- Pharmaceutical Science 68
- Molecular Medicine 21
- Oncology 109
- Biomedical Engineering 127
Countries citing papers authored by Edward Agyare
This map shows the geographic impact of Edward Agyare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Agyare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Agyare more than expected).
Fields of papers citing papers by Edward Agyare
This network shows the impact of papers produced by Edward Agyare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Agyare. The network helps show where Edward Agyare may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Agyare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 71 | |
| 2 | 2019 | 50 | |
| 3 | 2015 | 48 | |
| 4 | 2021 | 30 | |
| 5 | 2018 | 29 | |
| 6 | 2017 | 24 | |
| 7 | Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse. | 2016 | 24 |
| 8 | Evaluation of in-vitro cytotoxic effect of 5-FU loaded-chitosan nanoparticles against spheroid models. | 2018 | 23 |
| 9 | 2014 | 13 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 10 | |
| 12 | Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines. | 2015 | 10 |
| 13 | In vitro and in vivo antitumor activity of gemcitabine loaded thermosensitive liposomal nanoparticles and mild hyperthermia in pancreatic cancer. | 2015 | 9 |
| 14 | 2023 | 7 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2025 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2014 | 1 |
About Edward Agyare
Edward Agyare is a scholar working on Oncology, Biomaterials, Biomedical Engineering, Cancer Research and Molecular Biology, having authored 22 papers that have together received 378 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Pancreatic and Hepatic Oncology Research (9 papers), Nanoplatforms for cancer theranostics (5 papers), Cancer Genomics and Diagnostics (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Research and Treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Biomaterials (201 citations), Pharmaceutical Science (68 citations), Molecular Medicine (21 citations), Oncology (109 citations) and Biomedical Engineering (127 citations). Edward Agyare has collaborated with scholars based in United States and Cameroon. Frequent co-authors include José G. Treviño, Sunil Krishnan, Bo Han, Sunil Krishnan, Felix Amissah, Edward Ofori, Patrick W. Underwood, Jens T. Rosenberg, Xue Y. Zhu and Mandip Singh. Their work appears in journals such as BMC Cancer, Cancers, Scientific Reports, AAPS PharmSciTech and Journal of the National Medical Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.